Salubris refiles for Hong Kong IPO as generics lose steam
The producer of cardiovascular drugs is accelerating its shift towards innovative pharmaceuticals, under pressure from price cuts and expiring patents Key Takeaways: Salubris built its early success on generics, but…
Excelland Robotics leaps in trading debut despite tepid international interest
Shares of robotics manufacturer Excelland Robotics (Wuxi) Co. Ltd. (3231.HK) opened 142% above their IPO price in their trading debut on Wednesday, and climbed through the morning session to end…
Mech-Mind debuts as Hong Kong’s first ‘embodied intelligence eye-brain-hand’ stock
The company, which serves more than 100 Fortune Global 500 companies, derives over half its revenue overseas, and counts Baillie Gifford among its cornerstone investors By Teri Yu Intelligent robot-component…
Shein shares slump in highly anticipated Hong Kong trading debut
Shares of online fashion retailer Shein Global Holdings Ltd. (0625.HK) opened flat in their highly anticipated Hong Kong trading debut on Tuesday, then traded down during the morning to close…
Qdama misses listing window as revenue slumps, profit stagnates
China's largest community-based fresh food chain has reapplied to list in Hong Kong, planning to use the funds to boost its store network and supply chain capabilities Key Takeaways: Qdama…
NASN Tech jumps in trading debut as first-quarter revenue rises nearly 47%
NASN Intelligent Tech (Zhejiang) Co. Ltd. (2261.HK), a Chinese provider of motion control solutions for intelligent driving, opened up 62.2% in its Hong Kong trading debut on Friday and traded…
Shein passes listing hearing, advancing Hong Kong IPO
The online fashion retailer could launch its listing in the weeks ahead, as it continues its aggressive overseas expansion By Teri Yu Online fashion and lifestyle retailer Shein Global Holdings…
Recent Articles
RELATED ARTICLES
-
CSPC Innovation pursues Hong Kong IPO as parent profits shrink
300765.SHE -
BRIEF: Capital Securities gets regulatory nod, refiles for Hong Kong IPO
601136.SHG
-
Drug setback leaves Ascletis with an all-in bet on weight loss
1672.HK
- Jacobio Pharma poised to turn a profit from precision cancer drugs
-
Drug spin-off trend gains traction with IPO by Hengrui offshoot
1276.HK600276.SHG
- Precision-drug maker Impact Therapeutics ignites IPO frenzy
-
Alebund soars in Hong Kong debut on kidney treatment hopes
9637.HK
